Sort
51,593 grants matching “hepatitis”
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$720,966Douglas K Owens · Stanford University · R37 · FY2019 · DA
Mechanisms of Behavior Change Resource Core for Alcohol-HIV Interventions
$720,947Christopher W. Kahler · Brown University · U24 · FY2012 · AA
Integrating low-cost and versatile technologies to achieve colorimetric HCV and HIV detection from whole blood
$720,805David Richard Myers · Emory University · R01 · FY2025 · AI
HIV and Hepatitis C Pathogenesis & The Human Genome
$720,712David L Thomas · Johns Hopkins University · R01 · FY2018 · DA
HIV and Hepatitis C Pathogenesis & The Human Genome
$720,712David L Thomas · Johns Hopkins University · R01 · FY2017 · DA
Focal Myocardial Delivery of Small Molecule Nitroalkenes using Ultrasound Targeted Microbubble Cavitation to Improve Ventricular Recovery Following Myocardial Infarction
$720,676John J Pacella · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Drug target validation of the enterovirus D68 2A protease
$720,664Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
Automated quantification of lipid droplets in fatty liver tissue sections
$720,643Patrick M McDonough · Vala Sciences, Inc. · R42 · FY2012 · DK
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
$720,632Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR
Photoabsorbing bioinks for expanding 3D printed human liver in situ
$720,504Kelly R Stevens · University Of Washington · R01 · FY2022 · DK
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and women
$720,497Simin Liu · Brown University · R01 · FY2020 · DK
Predictors of Youth-Onset Type 2 Diabetes: UAB Clinical Center
$720,293Barbara A. Gower · University Of Alabama At Birmingham · U01 · FY2024 · DK
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$720,185Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2019 · AI
Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of Sepsis
$720,159Jamey Marth · University Of California Santa Barbara · R01 · FY2015 · HL
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$719,974Scott Dexter Boyd · Stanford University · R01 · FY2020 · AI
Control of vesicular trafficking in the hepatocyte.
$719,937Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2014 · DK
Control of vesicular trafficking in the hepatocyte.
$719,937Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2013 · DK
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$719,898Justin Richard Bailey · Johns Hopkins University · R01 · FY2018 · AI
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression
$719,784Raymond T Chung · Massachusetts General Hospital · R01 · FY2015 · DK
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$719,568Justin Richard Bailey · Johns Hopkins University · R01 · FY2019 · AI
Predict, Detect, Diagnose: Confronting Outbreaks of HIV and Other Infectious Diseases Among People Who Use Drugs
$719,401Gregg Steven Gonsalves · Yale University · R01 · FY2024 · DA
Impact on opioid use of bundling medication-assisted treatment with mHealth
$719,353David H Gustafson · University Of Wisconsin-Madison · R01 · FY2015 · DA
Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio
$719,153William C Miller · Ohio State University · UH3 · FY2019 · DA
The Progression of Hepatitis C Among IDUs with HIV
$719,084David L Thomas · Johns Hopkins University · R01 · FY2014 · DA
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
$718,916Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA